Eleven Biotherapeutics reported $0 in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amgen AMGN:US $ 6594M 356M
Bayer BAYN:GR € 12819M 1820M
Bristol Myers Squibb BMY:US $ 11887M 239M
Corcept Therapeutics CORT:US $ 103.39M 9.7M
Eleven Biotherapeutics EBIO:US $ 0M 20M
Eli Lilly And LLY:US $ 6488M 1322M
Intrexon XON:US $ 2.91M 29.11M
Merk MRK:US $ 14593M 1308M
Pfizer PFE:US $ 27742M 2081M
Rigel Pharmaceuticals RIGL:US $ 29.82M 13.08M
Roche Holding ROG:VX 16.44B 474M